DIMS Lenses May Slow Myopia Progression
A nearly decade-long observational follow-up found continued slowing of axial elongation into late adolescence, while refractive outcomes remained less consistent.
By
Andrea Surnit
July 8, 2026
Clinical Scorecard: DIMS Lenses May Slow Myopia Progression
At a Glance
Category Detail
Condition Myopia Key Mechanisms DIMS lenses slow axial elongation of the eye. Target Population Pediatric patients aged 8 to 13 years at baseline. Care Setting Observational posttrial follow-up study.
Key Highlights
DIMS lenses associated with 65% reduction in axial elongation over nearly 10 years. Cumulative axial elongation predicted at 0.44 mm for DIMS wearers vs. 1.27 mm for single-vision wearers. Less definitive findings for refractive error progression. Greatest treatment effect observed in younger patients, particularly before age 18. Study highlights need for further research with appropriate control groups. Guideline-Based Recommendations
Diagnosis
Monitor axial length and refractive error in pediatric myopia patients. Management
Consider DIMS lenses for slowing axial elongation in myopic children. Monitoring & Follow-up
Long-term follow-up required to assess sustained effects on eye growth. Risks
Potential survivor bias due to attrition over the study period. Patient & Prescribing Data
Pediatric patients previously exposed to DIMS lenses.
DIMS lenses may provide durable control of axial elongation.
Clinical Best Practices
Utilize longitudinal analysis for assessing treatment effects in myopia management. Incorporate normative data for contextual benchmarking in myopia studies. Acknowledge limitations of observational studies when interpreting results. Related Resources & Content
